Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
49
ACT Quote, Financials, Valuation and Earnings
Last price:
$35.11
Seasonality move
:
11.77%
Day range:
$34.25 - $34.84
52-week range:
$30.79 - $37.97
Dividend yield:
2.2%
P/E ratio:
7.83x
P/S ratio:
4.44x
P/B ratio:
1.02x
Volume:
312.2K
Avg. volume:
474.5K
1-year change:
4.67%
Market cap:
$5.2B
Revenue:
$1.2B
EPS (TTM):
$4.44
Earnings Data
Next earnings date for ACT
Jul 30
2025
Most recent earnings per share
$1.08
Missed by $0.01
(Apr 30/2025)
Consensus Estimate
$1.09
(Apr 30/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ACT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $311.9M | -- | -- | $1.10 | -- |
| 07/30/2025 | Q2 | $307.5M | -- | -- | $1.11 | -- |
| 04/30/2025 | Q1 | $302.2M | $306.9M | $1.08 | $1.09 | -$0.01 |
| 02/04/2025 | Q4 | $310.3M | $304.7M | $1.05 | $1.08 | -$0.03 |
| 11/06/2024 | Q3 | $306.7M | $309.6M | $1.15 | $1.09 | $0.06 |
| 07/31/2024 | Q2 | $299.4M | $298.8M | $1.16 | $1.03 | $0.13 |
| 05/01/2024 | Q1 | $293.7M | $291.6M | $1.01 | $0.97 | $0.04 |
| 02/06/2024 | Q4 | $297.4M | $296.2M | $0.98 | $0.95 | $0.03 |
| 11/01/2023 | Q3 | $292.5M | $299M | $1.02 | $0.90 | $0.12 |
| 06/30/2023 | Q2 | $284.2M | $277.5M | $1.04 | $0.86 | $0.19 |
| 03/31/2023 | Q1 | -- | $280.9M | $1.08 | -- | -- |
| 12/31/2022 | Q4 | -- | $276.7M | $0.88 | -- | -- |
| 09/30/2022 | Q3 | -- | $275.1M | $1.17 | -- | -- |
| 06/30/2022 | Q2 | -- | $273.5M | $1.25 | -- | -- |
| 03/31/2022 | Q1 | -- | $269.6M | $1.01 | -- | -- |
| 12/31/2021 | Q4 | -- | $275.2M | $0.95 | -- | -- |
| 09/30/2021 | Q3 | -- | $280.3M | $0.84 | -- | -- |
| 06/30/2021 | Q2 | -- | $277.4M | $0.80 | -- | -- |
| 03/31/2021 | Q1 | -- | $289.4M | $0.77 | -- | -- |
| 12/31/2020 | Q4 | -- | $285.5M | $0.56 | -- | -- |
| 09/30/2020 | Q3 | -- | $284.3M | $0.85 | -- | -- |
Enact Holdings Earnings Questions
-
How Much did Enact Holdings Generate in Revenue Last Quarter?
Enact Holdings reported $306.9M worth of top line sales in its most recent quarter.
-
Did Enact Holdings Beat Earnings Last Quarter?
Enact Holdings announced earnings per share of $1.08 which represents a miss of analyst forecast a $1.09 per share.
-
Is Enact Holdings Profitable?
Enact Holdings reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Enact Holdings EPS Next Year?
Enact Holdings's earnings are forecast to grow from $4.37 per share to $4.55 per share next year representing an increase of 1.43%.
-
When is Enact Holdings's Earnings Date?
Enact Holdings's next earnings date is July 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
